Hypertrophic Cardiomyopathy - Prof. Perry Elliott

This is a recording from the Cardiomyopathy UK 2022 Conference.
Our conferences bring together leading cardiomyopathy clinicians to present and respond to audience questions.
In this video, Professor Perry Elliot - President of Cardiomyopathy UK, discusses Hypertrophic Cardiomyopathy (HCM) and Hypertrophic obstructive Cardiomyopathy (HoCM).
Key topics:
00:00:55 - What is hypertrophic cardiomyopathy?
00:09:58 - How many people are affected by hypertrophic cardiomyopathy?
00:11:45 - How is hypertrophic cardiomyopathy diagnosed?
00:16:42 - What is the impact of hypertrophic cardiomyopathy?
00:19:44 - What is the management for hypertrophic cardiomyopathy?
00:22:58 - What is an ICD / S-ICD?
00:25:31 - What is the risk of sudden cardiac death?
00:28:21 - What is left ventricular outflow tract obstruction?
00:31:08 - Disopyramide
00:32:57 - What are the surgical interventions for hypertrophic cardiomyopathy?
00:35:48 - What is Mavacamten?
00:37:31 - What is the stroke risk in hypertrophic cardiomyopathy?
00:39:58 - What is heart failure?
Audience questions:
00:43:00 - Should treatment of stroke be the same for people with HoCM as the general population?
00:44:18 - What is ‘Widowmaker Syndrome'?
00:44:47 - Why is the risk of sudden cardiac death higher in those aged 20-30 years?
00:47:48 - Can you explain the connection between heart murmur and hypertrophic cardiomyopathy?
00:49:21 - How do the American guidelines on risk differ from those in the UK?
00:54:28 - Is there a link between life events and hypertrophic cardiomyopathy?
00:56:31 - Would new drugs such as Mavacamten mean that you could have an ICD removed?
00:59:10 - Does risk of hypertrophic cardiomyopathy increase with diabetes?
00:59:41 - Why do cardiologists opinions differ in their assessment of hypertrophic cardiomyopathy?
01:05:01 - Why is asthma confused with a symptom of hypertrophic cardiomyopathy?
01:08:02 - Is Mavacamten being used in other countries? Are there trials in the UK?
01:10:54 - Is there any indication of what may put someone at risk of a stroke?
01:12:35 - Should everyone have gene testing?
01:17:53 - Should we be requesting more frequent consultations due to the rapid developments in cardiomyopathy therapies?
01:19:51 - What is the future of treatment for hypertrophic cardiomyopathy?
01:21:54 - Is the risk for males the same as females?
01:22:30 - Should very young children be genetically tested?
01:26:39 - Should I have genetic testing if there is hypertrophic cardiomyopathy in other family members?
Access free information, find out about support groups and speak with cardiomyopathy Specialist Nurses at www.cardiomyopathy.org

[@oenrob98000]

Dr Elliott is such a vibe! 💖

[@simonmaverick9201]

Fantastic as always.

[@apuput]

It would have been more useful if the slides were actually more in focus rather than the audience. Otherwise, great lecture

[@baxtersermania7297]

Promo-SM